샘플 요청 목록

 카트 문의
시장보고서
상품코드
1779738

세계의 세포 동결 보존 시장

Cell Cryopreservation
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 387 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 세포 동결 보존 시장은 2030년까지 314억 달러에 달할 전망

2024년에 108억 달러로 추정되는 세계의 세포 동결 보존 시장은 2024-2030년에 CAGR 19.4%로 성장하며, 2030년에는 314억 달러에 달할 것으로 예측됩니다. 세포 동결 보존 리포트에서 분석한 부문의 하나인 소모품은 CAGR 22.1%를 기록하며, 분석 기간 종료까지 191억 달러에 달할 것으로 예측됩니다. 세포 동결 배지 부문의 성장률은 분석 기간 중 CAGR 17.4%로 추정됩니다.

미국 시장은 29억 달러로 추정, 중국은 CAGR 26.6%로 성장 예측

미국의 세포 동결 보존 시장은 2024년에 29억 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 75억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년의 CAGR은 26.6%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 각각 분석 기간 중 15.2%와 17.5%의 CAGR로 성장할 것으로 예측됩니다. 유럽에서는 독일이 CAGR 약 16.3%로 성장할 것으로 예측됩니다.

세계의 세포 동결 보존 시장 - 주요 동향과 촉진요인 정리

세포 동결보존에 대한 수요가 증가하는 이유는 무엇인가?

세포 동결보존에 대한 수요는 재생의료, 바이오의약품 연구, 세포 기반 치료법의 급격한 성장으로 인해 증가하고 있습니다. 동결보존은 줄기세포, 면역세포, 생식세포, 유전자 재조합세포 등 생물학적 물질을 연구 및 임상 응용에 장기적으로 사용하기 위해 보존하는 중요한 과정입니다. 맞춤형 의료의 보급과 줄기세포 치료의 발전에 따라 세포의 생존성과 기능성을 확보하기 위해 신뢰할 수 있는 동결보존 기술이 필수적으로 요구되고 있습니다.

또한 재생치료, 면역치료, 유전자 편집 기술에 초점을 맞춘 임상시험이 증가하면서 고품질 동결보존 솔루션의 필요성이 더욱 커지고 있습니다. 병원, 연구기관, 생명공학 기업은 미래의 의료용으로 사용하기 위해 생존 가능한 세포를 저장하고 운반하기 위해 냉동보존에 의존하고 있습니다. 종양학, 신경학, 생식의학 분야에서 세포 기반 치료에 대한 수요가 증가함에 따라 세포 동결보존 시장은 지속적으로 확대될 것으로 예측됩니다.

기술의 발전은 세포 동결보존을 어떻게 개선하고 있는가?

동결보호제 제제, 자동 동결 시스템, 극저온 보존 솔루션의 혁신은 세포 동결보존의 효율성과 신뢰성을 높이고 있습니다. 가장 중요한 발전 중 하나는 얼음 결정의 형성을 방지하고 동결보존 세포의 생존율을 향상시키는 유리화 기술의 개발입니다. 기존의 느린 동결 방법과 달리 유리화는 초급속 동결이 가능하여 세포의 무결성을 유지하고 동결 손상의 위험을 줄일 수 있습니다.

또 다른 큰 혁신은 AI를 활용한 모니터링 시스템과 자동 액체질소 저장시설의 활용입니다. 이러한 기술은 최적의 온도 관리를 보장하고, 시료의 열화를 최소화하며, 저장된 세포의 실시간 추적을 가능하게 합니다. 또한 동결 보호제의 발전은 해동 후 세포 회복을 개선하는 동시에 독성 위험을 감소시키고 있습니다. 바이오뱅크의 데이터 보안과 추적성을 위한 블록체인 통합은 동결보관 과정의 투명성과 컴플라이언스를 강화하며 인기를 끌고 있습니다. 냉동 프로토콜과 보존 인프라의 지속적인 개선으로 세포 동결보존은 더욱 효율적이고 확장성이 높아져 여러 의료 및 연구 분야에서 쉽게 사용할 수 있게 되었습니다.

세포 동결보존 산업의 성장을 촉진하는 시장 동향은?

줄기세포은행과 재생의료에 대한 수요 증가는 세포 동결보존 시장을 형성하는 가장 영향력 있는 동향 중 하나입니다. 척수손상, 자가면역질환, 심장질환 등의 질환에 대한 줄기세포 치료를 위해서는 생존 가능한 세포의 장기 보존이 필요하며, 이를 위해 냉동보존 기술에 대한 투자가 촉진되고 있습니다. 또한 불임 치료 보존이 주요 성장 분야로 부상하고 있으며, 미래의 생식 이용을 위해 난자, 정자, 배아 동결을 선택하는 사람들이 증가하고 있습니다.

시장 성장에 영향을 미치는 또 다른 주요 동향은 바이오뱅크 구상의 확대입니다. 정부와 연구기관은 유전체 연구, 신약개발, 맞춤형 의료를 지원하기 위해 대규모 바이오리포지토리에 투자하고 있습니다. 또한 생물학적 샘플의 원격 수집 및 보존을 가능하게 하는 분산형 동결보존 서비스의 부상도 견인차 역할을 하고 있습니다. 또한 바이오뱅크 및 세포치료제 제조에 대한 규제의 발전으로 인해 GMP(Good Manufacturing Practice)와 윤리적 가이드라인을 준수하는 산업이 형성되고 있습니다. 다양한 분야에서 세포 보존에 대한 요구가 증가함에 따라 향후 수년간 시장이 크게 확대될 것으로 예측됩니다.

세포 동결보존 시장의 미래를 형성하는 주요 성장 촉진요인은 무엇인가?

세포 동결보존 시장의 성장은 만성질환의 유병률 증가, 세포 기반 치료법의 발전, 생식 의학의 용도 확대 등 여러 요인에 의해 이루어지고 있습니다. 주요 성장 요인 중 하나는 암 치료를 위한 CAR-T 세포치료제 등 세포면역치료제 임상시험이 증가하고 있다는 점입니다. 이러한 치료에는 안정적이고 생존 가능한 세포의 보존이 필요하며, 냉동보존은 첨단 치료 프로토콜에 필수적인 요소입니다.

시장을 형성하는 또 다른 중요한 촉진요인은 불임 치료 서비스의 인지도 향상과 채택입니다. 부모가 되는 시기가 늦어지는 것이 일반화되면서 냉동 보존된 생식세포에 대한 수요가 급증하고 있으며, 이는 전 세계에서 불임 치료 클리닉과 바이오뱅크의 확대로 이어지고 있습니다. 또한 줄기세포 연구와 재생의료 구상에 대한 정부의 지원은 냉동보존 인프라에 대한 투자를 촉진하고 있습니다. 새로운 치료 용도가 속속 등장하면서 신뢰할 수 있는 고품질 세포 동결보존 솔루션에 대한 수요는 계속 증가하고 있으며, 시장은 앞으로도 지속적으로 성장할 것으로 예측됩니다.

부문

제품(보존 소모품, 배지, 보존 기기), 용도(줄기세포, 난모세포·배세포, 정자 세포, 간세포, 기타 용도), 최종 용도(체외수정 클리닉, 바이오의약품·제약회사, 바이오뱅크, 연구기관, 기타)

조사 대상 기업의 예

  • Avantor Inc.
  • Biocision, LLC
  • BioLife Solutions Inc.
  • Cardinal Health, Inc.
  • Cesca Therapeutics Inc.
  • Chart Industries, Inc.
  • Corning Incorporated
  • Creative Biolabs
  • CryoLife, Inc.
  • Custom Biogenic Systems
  • Danaher Corporation
  • GE Healthcare
  • Helmer Scientific
  • HiMedia Laboratories
  • Lonza Group Ltd.
  • Merck KGaA
  • Organ Recovery Systems Inc.
  • PromoCell GmbH
  • Sartorius AG
  • Sigma-Aldrich Co. LLC

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.08.11

Global Cell Cryopreservation Market to Reach US$31.4 Billion by 2030

The global market for Cell Cryopreservation estimated at US$10.8 Billion in the year 2024, is expected to reach US$31.4 Billion by 2030, growing at a CAGR of 19.4% over the analysis period 2024-2030. Cell Cryopreservation Consumables, one of the segments analyzed in the report, is expected to record a 22.1% CAGR and reach US$19.1 Billion by the end of the analysis period. Growth in the Cell Freezing Media segment is estimated at 17.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.9 Billion While China is Forecast to Grow at 26.6% CAGR

The Cell Cryopreservation market in the U.S. is estimated at US$2.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$7.5 Billion by the year 2030 trailing a CAGR of 26.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 15.2% and 17.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 16.3% CAGR.

Global Cell Cryopreservation Market - Key Trends & Drivers Summarized

Why Is the Demand for Cell Cryopreservation Increasing?

The demand for cell cryopreservation is increasing due to the rapid growth of regenerative medicine, biopharmaceutical research, and cell-based therapies. Cryopreservation is a critical process in storing biological materials such as stem cells, immune cells, reproductive cells, and genetically modified cells for long-term use in research and clinical applications. With the rising adoption of personalized medicine and advancements in stem cell therapy, the need for reliable cryopreservation techniques has become essential for ensuring cell viability and functionality.

Additionally, the increasing number of clinical trials focused on regenerative treatments, immunotherapies, and gene-editing technologies has further driven the need for high-quality cryopreservation solutions. Hospitals, research institutions, and biotechnology companies rely on cryopreservation to store and transport viable cells for use in future medical applications. As demand grows for cell-based treatments in oncology, neurology, and reproductive health, the cell cryopreservation market is poised for continued expansion.

How Are Technological Advancements Improving Cell Cryopreservation?

Innovations in cryoprotectant formulations, automated freezing systems, and cryogenic storage solutions are enhancing the efficiency and reliability of cell cryopreservation. One of the most significant advancements is the development of vitrification techniques, which prevent ice crystal formation and improve the survival rates of cryopreserved cells. Unlike traditional slow-freezing methods, vitrification allows for ultra-rapid freezing, preserving cellular integrity and reducing the risk of cryo-injury.

Another major breakthrough is the use of AI-driven monitoring systems and automated liquid nitrogen storage facilities. These technologies ensure optimal temperature control, minimize sample degradation, and provide real-time tracking of stored cells. Additionally, advancements in cryoprotective agents are reducing toxicity risks while improving post-thaw cell recovery. The integration of blockchain for data security and traceability in biobanking is also gaining traction, enhancing transparency and compliance in cryopreservation processes. With continuous improvements in freezing protocols and storage infrastructure, cell cryopreservation is becoming more efficient, scalable, and accessible across multiple medical and research fields.

Which Market Trends Are Driving Growth in the Cell Cryopreservation Industry?

The increasing demand for stem cell banking and regenerative medicine is one of the most influential trends shaping the cell cryopreservation market. Stem cell therapies for conditions such as spinal cord injuries, autoimmune disorders, and heart disease require long-term storage of viable cells, driving investments in cryopreservation technologies. Additionally, fertility preservation has emerged as a major growth area, with more individuals opting to freeze eggs, sperm, and embryos for future reproductive use.

Another key trend influencing market growth is the expansion of biobanking initiatives. Governments and research institutions are investing in large-scale biorepositories to support genomic research, drug discovery, and personalized medicine. The rise of decentralized cryopreservation services, which enable remote collection and storage of biological samples, is also gaining traction. Additionally, regulatory advancements in biobanking and cell therapy manufacturing are shaping the industry, ensuring compliance with Good Manufacturing Practices and ethical guidelines. As the need for cell preservation grows across various sectors, the market is expected to experience significant expansion in the coming years.

What Are the Key Growth Drivers Shaping the Future of the Cell Cryopreservation Market?

The growth in the cell cryopreservation market is driven by several factors, including the increasing prevalence of chronic diseases, advancements in cell-based therapies, and expanding applications in reproductive health. One of the primary growth drivers is the rising number of clinical trials for cellular immunotherapies, such as CAR-T cell therapy for cancer treatment. These therapies require stable and viable cell storage, making cryopreservation an essential component of advanced treatment protocols.

Another crucial driver shaping the market is the increasing awareness and adoption of fertility preservation services. With delayed parenthood becoming more common, demand for cryopreserved reproductive cells has surged, leading to the expansion of fertility clinics and biobanks worldwide. Additionally, government support for stem cell research and regenerative medicine initiatives is fueling investments in cryopreservation infrastructure. As new therapeutic applications continue to emerge, the need for reliable, high-quality cell cryopreservation solutions will remain strong, positioning the market for sustained growth in the years ahead.

SCOPE OF STUDY:

The report analyzes the Cell Cryopreservation market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Cell Cryopreservation Consumables, Cell Freezing Media, Cell Cryopreservation Equipment); Application (Stem Cells Application, Oocytes and Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application, Other Applications); End-Use (IVF Clinics End-Use, Biopharmaceutical and Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Avantor Inc.
  • Biocision, LLC
  • BioLife Solutions Inc.
  • Cardinal Health, Inc.
  • Cesca Therapeutics Inc.
  • Chart Industries, Inc.
  • Corning Incorporated
  • Creative Biolabs
  • CryoLife, Inc.
  • Custom Biogenic Systems
  • Danaher Corporation
  • GE Healthcare
  • Helmer Scientific
  • HiMedia Laboratories
  • Lonza Group Ltd.
  • Merck KGaA
  • Organ Recovery Systems Inc.
  • PromoCell GmbH
  • Sartorius AG
  • Sigma-Aldrich Co. LLC

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Cell Cryopreservation - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Adoption of Cell-Based Therapies Throws the Spotlight on Cell Cryopreservation as a Foundational Bioprocess
    • Growing Demand for Long-Term Cell Storage Solutions Propels Market for Cryopreservation Media and Technologies
    • Expansion of Stem Cell Research and Regenerative Medicine Drives Need for Advanced Cryopreservation Systems
    • Boom in Cell and Gene Therapy Development Strengthens the Business Case for Reliable Cryopreservation Infrastructure
    • Increasing Use of Cryopreserved Cells in Clinical Trials and Manufacturing Pipelines Expands the Addressable Market
    • Technological Advancements in Cryoprotectants and Controlled-Rate Freezing Enhance Cell Viability and Recovery Rates
    • Growth in Biobanking Initiatives and Personalized Medicine Programs Fuels Large-Scale Cell Storage Needs
    • Emerging Demand from Fertility Preservation, Cord Blood Banking, and Reproductive Health Boosts Market Diversification
    • Automation and Digital Integration in Cryostorage Facilities Improve Operational Efficiency and Sample Traceability
    • Cold Chain Expansion and Logistics Infrastructure Development Support Scalable Cryopreservation Solutions
    • Increasing Application in Immunotherapy and CAR-T Cell Therapy Drives Demand for High-Fidelity Cryopreservation Systems
    • R&D in Alternative Cryoprotectant Agents and Vitrification Techniques Opens New Avenues for Innovation
    • Globalization of Biomanufacturing and Clinical Trials Creates Demand for Multi-Site Cryopreservation Capabilities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cell Cryopreservation Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cell Cryopreservation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Cell Cryopreservation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Cell Cryopreservation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Cell Cryopreservation Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Cell Cryopreservation Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Cell Cryopreservation Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Cell Freezing Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Cell Freezing Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Cell Freezing Media by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Cell Cryopreservation Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Cell Cryopreservation Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Cell Cryopreservation Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Biopharmaceutical & Pharmaceutical Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Biopharmaceutical & Pharmaceutical Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Biopharmaceutical & Pharmaceutical Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Biobanks End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Biobanks End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Biobanks End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for IVF Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for IVF Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for IVF Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Stem Cells Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Stem Cells Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Stem Cells Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Oocytes & Embryotic Cells Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Oocytes & Embryotic Cells Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Oocytes & Embryotic Cells Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Sperm Cells Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Sperm Cells Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Sperm Cells Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Hepatocytes Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Hepatocytes Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Hepatocytes Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cell Cryopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 44: USA Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: USA 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
  • JAPAN
    • Cell Cryopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
  • CHINA
    • Cell Cryopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 71: China Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
  • EUROPE
    • Cell Cryopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Cell Cryopreservation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Cell Cryopreservation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Cell Cryopreservation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
  • FRANCE
    • Cell Cryopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 92: France Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: France 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: France 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
  • GERMANY
    • Cell Cryopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Germany 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Germany 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Italy 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Italy 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Cell Cryopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 119: UK Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: UK 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 125: UK Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: UK 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Spain 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
    • TABLE 131: Spain Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Spain 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 134: Spain Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Spain Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Spain 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Russia 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
    • TABLE 140: Russia Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Russia 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 143: Russia Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Russia Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Russia 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Rest of Europe 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Europe Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of Europe 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Cell Cryopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Cell Cryopreservation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Cell Cryopreservation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Cell Cryopreservation by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Asia-Pacific Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Asia-Pacific 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Cell Cryopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Australia 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
    • TABLE 170: Australia Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Australia Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Australia 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 173: Australia Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Australia Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Australia 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
  • INDIA
    • Cell Cryopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 176: India Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: India 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
    • TABLE 179: India Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: India Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: India 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 182: India Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: India Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: India 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: South Korea 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
    • TABLE 188: South Korea Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: South Korea Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: South Korea 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 191: South Korea Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: South Korea Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: South Korea 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Asia-Pacific Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Asia-Pacific Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Cell Cryopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Cell Cryopreservation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Cell Cryopreservation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Cell Cryopreservation by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Latin America 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Latin America 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 212: Latin America Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Latin America Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Latin America 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Argentina 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
    • TABLE 218: Argentina Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Argentina Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Argentina 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 221: Argentina Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Argentina Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Argentina 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Brazil 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
    • TABLE 227: Brazil Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Brazil Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Brazil 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 230: Brazil Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Brazil Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: Brazil 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: Mexico 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
    • TABLE 236: Mexico Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Mexico Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: Mexico 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 239: Mexico Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Mexico Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: Mexico 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
    • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Rest of Latin America Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: Rest of Latin America 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Rest of Latin America Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: Rest of Latin America 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Cell Cryopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Cell Cryopreservation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Cell Cryopreservation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Cell Cryopreservation by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Middle East 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Middle East 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 260: Middle East Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Middle East Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Middle East 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Iran 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
    • TABLE 266: Iran Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Iran Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Iran 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 269: Iran Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Iran Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Iran 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Israel 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
    • TABLE 275: Israel Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Israel Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Israel 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 278: Israel Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Israel Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Israel 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
    • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Saudi Arabia Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Saudi Arabia 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Saudi Arabia Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: Saudi Arabia 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: UAE 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
    • TABLE 293: UAE Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: UAE Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: UAE 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 296: UAE Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: UAE Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: UAE 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
    • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Middle East Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Middle East 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Middle East Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Rest of Middle East 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030
  • AFRICA
    • Cell Cryopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Cell Cryopreservation by Product - Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 310: Africa 15-Year Perspective for Cell Cryopreservation by Product - Percentage Breakdown of Value Sales for Cell Cryopreservation Consumables, Cell Freezing Media and Cell Cryopreservation Equipment for the Years 2015, 2025 & 2030
    • TABLE 311: Africa Recent Past, Current & Future Analysis for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Africa Historic Review for Cell Cryopreservation by End-Use - Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 313: Africa 15-Year Perspective for Cell Cryopreservation by End-Use - Percentage Breakdown of Value Sales for Biopharmaceutical & Pharmaceutical Companies End-Use, Biobanks End-Use, Research Institutes End-Use, Other End-Uses and IVF Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 314: Africa Recent Past, Current & Future Analysis for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Africa Historic Review for Cell Cryopreservation by Application - Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 316: Africa 15-Year Perspective for Cell Cryopreservation by Application - Percentage Breakdown of Value Sales for Stem Cells Application, Oocytes & Embryotic Cells Application, Sperm Cells Application, Hepatocytes Application and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제